Following clinically relevant doses of PDT, reductions in tumor volume, glioma cell proliferative activity, and vascular endothelial growth factor expression were observed in the tumor area and adjacent brain tissue for 7 days. The gene discussed is VEGFA; the disease is central nervous system cancer.